This is a cost-plus-fixed-fee delivery order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Navy, to Leidos, Inc. for research support services. The base period of performance runs through June 2025 with a ceiling value of $16,210,413.50. The contract is not set aside for any specific business size or socioeconomic category. Leidos is a large, publicly traded information technology and engineering solutions provider that frequently competes for federal...
This is a federal contract award valued at $11,110,770.72 issued by the Bureau of Medicine and Surgery, a Defense agency, to Leidos, Inc. The contract is for research and development support services under an Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle. The award does not have a set-aside designation, indicating Leidos competed successfully as a large business. The contract work will be performed in Poquonock Bridge, Connecticut and has a period of performance through May 31, 2020....
This federal contract award, valued at $249,450.74, was issued by the Defense Health Agency to Leidos, Inc. to provide services for the Congressionally Directed Medical Research Programs' Autism Research Program. The contract is a Cost Plus Fixed Fee Delivery Order with a period of performance through March 31, 2026. No set-aside designation was used for this full and open competition award. Leidos, Inc., a global leader in IT, engineering, and scientific solutions, will deliver a range of...
This is a $3,659,815.92 Cost Plus Fixed Fee delivery order awarded to Leidos, Inc. by the Bureau of Medicine and Surgery (a component of the Department of the Navy) under the Navy Medicine R&D Support Omnibus III multiple-award IDIQ contract. The contract, which has no set-aside designation, is for the "Health Epidemiology Leveraging Improvements in Operational Sustainability (HEILOS)" project, which likely involves medical research and development in support of military health...
This is a $1,194,974.16 cost-plus-fixed-fee delivery order contract awarded by the Defense Health Agency to Leidos, Inc. for the Peer Reviewed Medical Research Program. The contract has a performance period ending on March 18, 2026. Leidos, a global technology and engineering solutions provider, will support critical medical research and development efforts across various domains for the Defense Health Agency, including work on traumatic brain injury, cancer, autism, and rare diseases. This...
This is a delivery order contract awarded by the Defense Health Agency to Leidos, Inc. for traumatic brain injury and psychological health support services under the Congressionally Directed Medical Research Programs. The $557,911.02 cost-plus-fixed-fee contract has a June 2024 completion date and was not set aside for any specific business category. Leidos, a global technology and engineering solutions provider, will deliver a range of technical, scientific, and administrative services to...
The Defense Health Agency awarded a $549,344.15 cost-plus-fixed-fee delivery order contract to Leidos, Inc. for peer reviewed medical research program support services. This work supports the Congressionally Directed Medical Research Programs. The contract was not set aside. Leidos, Inc. is a global leader in information technology, engineering, and science solutions, providing a wide range of products and services to U.S. government agencies, primarily in the areas of national security, health,...
This is a $9,303,241.09 cost-plus-fixed-fee delivery order contract awarded by the Bureau of Medicine and Surgery (part of the Department of Defense) to Leidos, Inc., operating through its Leidos Services Operating Segment Division and doing business as SAIC. The contract, which is not set-aside, is for "Operational Medicine" services with a performance period ending on March 17, 2026. Leidos, a global leader in information technology, engineering, and science solutions, has secured...
This is a $46,706,872.49 cost-plus-fixed-fee delivery order contract awarded by the Bureau of Medicine and Surgery (part of the Department of the Navy) to Leidos, Inc. for research support services. The contract has an ultimate completion date of July 19, 2026. It is not a set-aside contract. Leidos, Inc. is the prime contractor, and major subcontractors include Teamworks Tactical Solutions Inc., The Ohio State University, Appalachian State University, Matrix Industries Inc., and Fusion Sport...
This is a cost-plus-fixed-fee delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Leidos, Inc. The $17,486,778.06 contract is for research support services with an ultimate completion date of October 31, 2025. The contract is not set aside for small businesses. As a prime contractor, Leidos is leveraging its One Acquisition Solution for Integrated Services (OASIS) Indefinite Delivery Vehicle to provide these research support...
This is a delivery order under the Navy Medicine R&D Support Omnibus III contract, awarded by the Bureau of Medicine and Surgery (a Defense agency) to Leidos, Inc. for $10,434,530.44. The contract is for medical research program support, including services related to conditions such as traumatic brain injury, cancer, autism, and rare diseases. Leidos has subcontracted work to several companies, including Icon Government And Public Health Solutions, Inc., Camris International, LLC, and Venesco LLC, a small disadvantaged business. The contract does not have a set-aside designation, indicating Leidos' competitive capabilities across federal procurement. This award supports the Defense Health Agency's medical research initiatives.